Although it has been suspected that ~nfants born of drugaddicted mothers have an increased incidence of infections, it has been unclear whether this is due to social factors, increased exposore to infectious agents, or effects of the addicting drugs. Three groups of infants were followed through one year of age, and the incidence of infection was evaluated. Group A infants (N=21) were delivered to women w h o used heroin intravenously,
Group B infants (N=15) to women w h o abused nonopiate drugs orally and Group C infants (N=15) to women wlih no evidence of drug use. There was no difference In the three groups as to maternal age, education, race, income or cigarette use. More palients in Group A had an illness during the first year of life (18 of 21) compared to Group B ( 7 of 15) or Group C (8 of 15) (X2=7.0R, p<.01).
T A unique aspect of pediatric AIDS (PAIDS) is an additional susceptibility to infections characteristic of immunoglobulin (Ig) deficiency: otitis media, sinusitis, sepsis. To evaluate this clinical observation further, IgG subcalsses were determined in 3 infant boys with suspected AIDS and 4 adult homosexual men with AIDS. JP and PB, born at 28 and 29 weeks gestation, had received multiple blood transfusions in the neonatal period and died at 11 and 22 months, respectively, with P. carinii pneumonia
The mother of a third infant, MF, has AIDS, likely acquired from her i.v. drug abusing husband. This child has lymphoid interstitial pneumonia and sinusitis. Laboratory evaluation of these infants revealed reversed T he1per:suppressor ratios, decreased lymphoprol iferative responses to mi togens and hyperimunoglobulinemia G and A. JP's and PB's serum IgG levels declined as their disease progressed. In addition, JP has absent IgG2, PB had absent IgG3 and MF had absent IgG2 and IgG4. Other IgG subclasses were normal. In the 4 adult subjects, total IgG levels were increased and IgG subclasses were normal to increased.
The finding of selective IgG subclass deficiencies in PAIDS is consistent with the improvement seen in some of these patients following Ig replacement therapy. The normal IgG subclass values noted in the adult AIDS patients in association with a lack of characteristic infections indicate that Ig would not be of benefit in these patients.
COMMON VARIABLE IMMUNODEFICIENCY (CVI) OF CHILDHOOD
950 WITH AUTOIMMUNE DISEASE. M.E. Conley and Donald E. CVI in childhood is not a well described entity. We have followed 6 children (2 males and 4 females) with this disease who have also had multiple severe, autoimmune disorders that have overshadowed infections as clinical problems. These children have all had onset of disease before 5 years of age and all have had severe growth failure. The autoimmune disorders have included ITP with autoimmune hemolytic anemia (3/6), diarrhea, malabsorption or gastritis (5/6), JRA (2/6), parotitis (2/6), chronic active hepatitis (216) and Guillian ~arr; Syndrome (216). All have had hypogammaglobulinemia. T and B cells have been present in the peripheral circulation, although in some cases in reduced numbers. Delayed hypersensitivity skin tests and proliferative responses to mitogens have been normal. T cell subsets, done in 4 of the patients, demonstrated an increased ratio of T helpers to T suppressors (T41T8); 3.2 + 0.6 vs. ~ropiony I-COA (PCC) and pyruvate (PC) carbbxylase activities in DEF livers were 20% and 15% of CNT livers respectively. PCC in lymphocytes from T, S, and LN from DEF rats were 6%. 55% and 88% of CNT respectively. These results indicate: 1) T cell mitogen responses are most susceptible to biotin deficiency in the more differentiated LN; 2) PCC activity is most affected by biotin deficiency in the less differentiated T and is not the cause of depressed Con A responses by biotin deficient LN. It is possible that biotin metabolism and/or the role of biotin dependent carboxylases in lymphocytes changes with maturation and could explain the differential susceptibility of lymphocytes to the biotin deficient state.
MISMATCHED BONE MARROW TRANSPLANTATION (BMT) USING

SOYBEAN AGGLUTININ (SBA) NEGATIVE MARROW CELLS.
Morton Cowan, Arthur Ammann, Diane Wara, Weintrub, Henry Pabst, Natasha Martin and Nenita Arias. University of California, School of Medicine, San Francisco, California
The limitation of mismatched BMT is fatal graft vs. host disease (GVHD). We processed haplotype mismatched parental marrow with SBA to enrich for stem cells and reduce GVHD and successfully treated 6 patients with severe combined immune deficiency disease. HLA chimerism was found within 3 weeks post BMT. All the patients demonstrate T cell and 2 have evidence of B cell engraftment. T cell numbers and responses to phytohemagolutinln (PHA) and alloantioen Dre and oost BMT are: In the airway, gastrointestinal tract, renal parenchyma, and during some clinical situations, basophils and mast cells are exposed to a hyperosmolar milieu. We have shown that hyperosmolar stimuli release phamacologically active mediators and that the process is distinct from IgE-dependent release. Significant mast cell histamine release occurs at just above physiologic levels (360 m0sm) and reaches a maximum of 12'1% at 770 m0sm; release from basophils is significant at 560 mOsm and reaches a maximum of 45+7% at 1020 m0sm. ~ctivation of mast cells is dependent on extracellular ~a * but maximal release from basophils is only partially reduced in ~a * free buffers. Hyperosmolar buffers also increase IgE-dependent histamine release synergistically (mast cells: 460 mOsm 7 ' 1 % release; 1 ug/ml anti IgE 7'1%; both 27'4%). Prostaglandin D2 (PGD2) production from mast cells at 770 mOsm (69 pg/100 ~1 ) was not different from unstimulated cells (83 pg/100 u1) despite significant histamine release (16% vs. 4% control). Furthermore, IgE-dependent PGD2 production (264 pg1100 ~1 ) was suppressed (99 pg/100 u1) in hyperosmolar buffers (p<0.01).
The distinctive activation by hyperosmolarity and its interaction with IgEdependent activation may have important implications for airway physiology, and the management of radiocontrast anaphylactoid reactions and clinical hyperosmolarity syndromes.
